Multicenter Randomized Phase II Trial of Docetaxel With/Without VANDETANIB for Advanced Gastroesophageal Cancer
Phase of Trial: Phase II
Latest Information Update: 16 Aug 2012
At a glance
- Drugs Docetaxel (Primary) ; Vandetanib
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 09 Mar 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 31 Aug 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 03 Jun 2009 New trial record.